H-Thr(Bzl)-OH·HCl CAS:60856-51-1

I ka synthesis peptide, he kuleana koʻikoʻi ko H-Thr(Bzl)-OH·HCl ma ke ʻano he derivative amino acid i pale ʻia e hele ana i ka deprotection a me ka hoʻāla ʻana no ka hoʻopili ʻana me nā waikawa amino ʻē aʻe e hana i nā kaulahao peptide. Pono kēia kaʻina hana i ka nānā pono ʻana i nā kūlana hopena a me nā ʻano hana hoʻomaʻemaʻe e mālama i ka pono o ka hui a loaʻa nā huahana peptide kiʻekiʻe. Hoʻohui pono nā kānaka noiʻi a me nā ʻepekema lāʻau lapaʻau iā H-Thr(Bzl)-OH·HCl i kā lākou mau protocols synthetic e hana i nā moʻo peptide kikoʻī e hōʻike ana i ka hana olaola a i ʻole ka hiki ke therapeutic. He mea nui ka maʻemaʻe mau a me ke kūpaʻa o ka hui no ka hōʻoia ʻana i nā hopena hiki ke hana hou ʻia i ka synthesis peptide, e kōkua ana i ka hoʻomohala ʻana i nā moho lāʻau lapaʻau hou a me nā hui bioactive. Eia kekahi, ʻo ka kūlike o H-Thr(Bzl)-OH·HCl me nā ʻano hana synthesis solid-phase e hiki ai i kona hoʻokomo pono ʻana i loko o nā synthesizers peptide automated, e hoʻomaʻamaʻa ana i ka hana ʻana o nā peptides maʻamau a me nā hale waihona puke peptide no ka ʻike ʻana i nā lāʻau lapaʻau a me nā noi noiʻi. ʻO kāna kuleana i ka hoʻoulu ʻana i nā ʻano peptide like ʻole e lilo ia i mea hana waiwai no ka hoʻoponopono ʻana i nā pilikia biomedical like ʻole a me ka ʻimi ʻana i nā ala hou no nā hana therapeutic. Ma keʻano holoʻokoʻa, ʻo ke koʻikoʻi o H-Thr(Bzl)-OH·HCl i ka peptide synthesis e hoʻolaha ana ma o ka noiʻi lāʻau lapaʻau, biotechnology, a me ka kemika lāʻau lapaʻau, kahi e hoʻomau ai i ka hoʻomaʻamaʻa ʻana i ka hoʻokumu ʻana i nā therapeutics a me nā biopharmaceuticals e pili ana i ka peptide, e hoʻokele ana i nā holomua i ka mālama ola a me nā ʻepekema ola.